Skip to main content
Terug
Watch Compare

Aldeyra Therapeutics, Inc.

Datakwaliteit: 83%
ALDX
Nasdaq Manufacturing Chemicals
€ 1,58
▲ € 0,01 (0,32%)
Marktkapitalisatie: 94,79 M
Prijs
€ 1,58
Marktkapitalisatie
94,79 M
Dagbereik
€ 1,52 — € 1,63
52-Weeksbereik
€ 1,07 — € 6,18
Volume
2.056.783
Openen € 1,54
50D / 200D Gem.
€ 4,20
62,54% below
50D / 200D Gem.
€ 4,81
67,27% below

Quick Summary

Belangrijkste Punten

Debt/Equity of 0,31 — conservative balance sheet
Negative free cash flow of -33,35 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-64,76%
Onder sectorgemiddelde (-53,47%)
ROIC-53,19%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,31
Boven sectorgemiddelde (0,31)
Current Ratio2,72
Interest Coverage-18,51

Waardering

PE (TTM)
-2,80
Onder sectorgemiddelde (-1,47)
P/B Ratio1,92
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -2,8 -1,5
P/B 1,9 1,6
ROE % -64,8 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E 0,3 0,3

ETFs Holding This Stock

IRSSX IRSSX
0,01% weight
VVICX VVICX
0,01% weight
IRSIX IRSIX
0,01% weight
IIRSX IIRSX
0,01% weight
IRCIX IRCIX
0,01% weight
IWV logo IWV iShares Russell 3000 ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -33,85 M
ROE -64,76% ROA -41,59%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -33,35 M
ROIC -53,19% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,31 Current Ratio 2,72
Interest Coverage -18,51 Asset Turnover N/A
Working Capital 48,98 M Tangible Book Value 49,24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,80 Forward P/E N/A
P/B Ratio 1,92 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -35,18%
Market Cap 94,79 M Enterprise Value 50,75 M
Per Share
EPS (Diluted TTM) -0,56 Revenue / Share N/A
FCF / Share -0,55 OCF / Share -0,55
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 98,52%
SBC-Adj. FCF -41,57 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -33,85 M -55,85 M -37,54 M -62,02 M -57,78 M
EPS (Diluted) -0,56 -0,94 -0,64 -1,06 —
Gross Profit — — — — —
Operating Income -35,27 M -60,12 M -42,79 M -62,68 M -56,22 M
EBITDA — — — — —
R&D Expenses 25,66 M 48,22 M 29,46 M 47,31 M 44,94 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 1,91 M 1,93 M 2,07 M 1,69 M 1,74 M
Income Tax 0,0 1.000,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 72,06 M 104,61 M 148,33 M 181,29 M 233,14 M
Total Liabilities 27,81 M 33,60 M 28,53 M 30,28 M 27,40 M
Shareholders' Equity 44,25 M 71,00 M 119,80 M 151,01 M 205,74 M
Total Debt 15,30 M 15,30 M 15,29 M 16,34 M 16,04 M
Cash & Equivalents 70,04 M 54,53 M 144,42 M 144,42 M 229,79 M
Current Assets 71,78 M 104,07 M 147,81 M 181,02 M 232,75 M
Current Liabilities 27,81 M 18,60 M 22,26 M 15,36 M 11,77 M